Anteilseigner
Bellevue Asset Management AG (16,50 %) T. Rowe Price Investment Management, Inc. (12,91 %) Versant Venture Management LLC (12,43 %) NEA Management Co. LLC (8,60 %) RA Capital Management LP (6,82 %) Invus Public Equities Advisors LLC (3,96 %) The Vanguard Group, Inc. (3,73 %) Tang Capital Management LLC (3,49 %) Verition Fund Management LLC (3,01 %) David M. Epstein (1,81 %) Deerfield Management Co. LP (Private Equity) (1,80 %) BlackRock Advisors LLC (1,61 %) JPMorgan Securities LLC (Investment Management) (1,59 %) Kennedy Capital Management LLC (1,43 %) CHI Advisors LLC (1,39 %) Driehaus Capital Management LLC (1,35 %) Blue Owl Healthcare Opportunities Advisors LLC (1,34 %) Ally Bridge Group HK Ltd (1,23 %) Ikarian Capital LLC (1,07 %) Boxer Capital LLC (0,98 %)
Kontakt
Black Diamond Therapeutics Inc.